{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T03:08:55Z","timestamp":1784171335500,"version":"3.55.0"},"reference-count":17,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[1997,8,1]],"date-time":"1997-08-01T00:00:00Z","timestamp":870393600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T00:00:00Z","timestamp":1578355200000},"content-version":"vor","delay-in-days":8194,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[1997,8]]},"DOI":"10.1023\/a:1008210527637","type":"journal-article","created":{"date-parts":[[2002,12,22]],"date-time":"2002-12-22T08:47:34Z","timestamp":1040546854000},"page":"739-744","source":"Crossref","is-referenced-by-count":9,"title":["Randomized study of zorubicin versus zorubicin-cisplatin in undifferentiated carcinoma of the nasopharynx (UCNT)"],"prefix":"10.1016","volume":"8","author":[{"given":"S.","family":"Jeli\u0107","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Kov\u010din","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Milanovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Krea\u010di\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Pendjer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Jovanovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.","family":"Ristovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Opri\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Mitrovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1023\/A:1008210527637_bb0100","doi-asserted-by":"crossref","first-page":"531","DOI":"10.3109\/02841869309096113","article-title":"Prognostic factors in patients with nasopharyngeal carcinoma","volume":"32","author":"Kaasa","year":"1993","journal-title":"Acta Oncol"},{"key":"10.1023\/A:1008210527637_bb0105","series-title":"Chemotherapy of nasopharyngeal cancer: A review of current status and future prospects. EORTC Symposium on Recent Advances in Cancer Management","author":"Guan","year":"1987"},{"key":"10.1023\/A:1008210527637_bb0110","series-title":"EORTC Symposium on Recent Advances in Cancer Management","first-page":"18","article-title":"Phase II clinical trial of 4-epidoxorubicin in nasopharyngeal carcinoma","author":"Law","year":"1987"},{"key":"10.1023\/A:1008210527637_bb0115","first-page":"63","article-title":"Effectiveness of zorubicincisplatin combination chemotherapy for undifferentiated carcinoma of the nasopharynx (UCNT): A study in 37 patients","volume":"1","author":"Jeli\u0107","year":"1990","journal-title":"Ann Oncol"},{"key":"10.1023\/A:1008210527637_bb0120","series-title":"Abst. Symp. Rubidazone: Current Status and Future Developments, 14th International Cancer Congress UICC, Budapest","article-title":"Rubidazone general toxicity and cardiotoxity","author":"Gisselbrecht","year":"1986"},{"key":"10.1023\/A:1008210527637_bb0125","series-title":"Abst. Symp. Rubidazone: Current Status and Future Developments, 14th International Cancer Congress UICC, Budapest","article-title":"Experimental studies of Rubidazone","author":"Lavelle","year":"1986"},{"key":"10.1023\/A:1008210527637_bb0130","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6","article-title":"Reporting results of cancer treatment","volume":"47","author":"Milles","year":"1981","journal-title":"Cancer"},{"issue":"7","key":"10.1023\/A:1008210527637_bb0135","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1002\/1097-0142(19901001)66:7<1453::AID-CNCR2820660703>3.0.CO;2-X","article-title":"Induction chemotherapy with a new regimen alternating cisplatin, fluorouracil with mitomycin, hydroxyurea and blomycin in carcinomas of nasopharynx or other sites of the head and neck region","volume":"66","author":"Fountzilas","year":"1990","journal-title":"Cancer"},{"issue":"6","key":"10.1023\/A:1008210527637_bb0140","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S0889-8588(18)30418-0","article-title":"Nasopharyngeal carcinoma","volume":"5","author":"Cvitkovi\u0107","year":"1991","journal-title":"Biology, natural history and therapeutic implications. Hematol Oncol Clin North Am"},{"issue":"7","key":"10.1023\/A:1008210527637_bb0145","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1093\/jnci\/82.7.616","article-title":"High complete response in advanced nasopharyngeal carcinoma with bleomycin, epirubicin and cisplatin before radiotherapy","volume":"82","author":"Bachouchi","year":"1990","journal-title":"J Natl Cancer Inst"},{"key":"10.1023\/A:1008210527637_bb0150","first-page":"A915","article-title":"Neoadjuvant chemotherapy (NACT) with epirubicin (EP1), cipslatin (CDDP), bleomycin (BLEO) (BEC) in undifferentiated nasopharyngeal cancer (UCNT): Preliminary results of an international (INT) phase (PH) III trial","volume":"13","author":"Cvitkovi\u0107","year":"1994","journal-title":"Proc Annu Meet Am Soc Clin Oncol"},{"key":"10.1023\/A:1008210527637_bb0155","series-title":"Third International Congress on the Neoadjuvant Chemotherapy","first-page":"8","article-title":"TAvo-years follow-up on bleomycin (B), epirubicin (E), cisplatin (P) in locally advanced undifferentiated carcinoma nasopharyngeal type (UCNT)","author":"Bachouchi","year":"1991"},{"issue":"4","key":"10.1023\/A:1008210527637_bb0160","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/0360-3016(88)90082-X","article-title":"Acute and late toxicity associated with sequential bleomycin-containing chemotherapy regimens and radiation therapy in the treatment of carcinoma of the nasopharynx","volume":"14","author":"Peters","year":"1988","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1023\/A:1008210527637_bb0165","first-page":"A682","article-title":"Neoadjuvant chemotherapy in nasopharyngeal carcinoma combined with radiotherapy","volume":"9","author":"Boussen","year":"1990","journal-title":"Comparative analysis of two protocols: adriamycin\u2013bleo\u2013platinum\/ adria\u2013platinum. Proc Annu Meet Am Soc Clin Oncol"},{"issue":"3\u20134","key":"10.1023\/A:1008210527637_bb0170","first-page":"111","article-title":"Chemotherapy with doxorubicin and CCNU in advanced undifferentiated carcinoma the nasopharynx","volume":"31","author":"de Graeff","year":"1987","journal-title":"A retrospective report on five patients. Neth J Med"},{"key":"10.1023\/A:1008210527637_bb0175","first-page":"1002","article-title":"Etude pilote de la zorubicine \u00e0 hautes doses dans les stades avanc\u00e9s des sarcomes des tisstis mous de l\u2019adulte","volume":"83","author":"Jeli\u0107","year":"1996","journal-title":"Bull Cancer"},{"key":"10.1023\/A:1008210527637_bb0180","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/BF00685041","article-title":"Combination of daily 4-h infusion of 5-fluorouracil and cisplatin in the treatment of advanced head and neck squamous-cell carcinoma: A South-East European Oncology Group study","volume":"31","author":"Jassem","year":"1993","journal-title":"Cancer Chemother Pharmacol"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419483555?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419483555?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/8\/8\/739\/19481143\/8-8-739.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T12:06:35Z","timestamp":1582200395000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419483555"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,8]]},"references-count":17,"journal-issue":{"issue":"8","published-print":{"date-parts":[[1997,8]]}},"alternative-id":["S0923753419483555"],"URL":"https:\/\/doi.org\/10.1023\/a:1008210527637","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[1997,8]]}}}